Volume 64, Issue 6, Pages (December 2003)

Slides:



Advertisements
Similar presentations
Acid-base profile in patients on PD
Advertisements

Volume 63, Issue 3, Pages (March 2003)
Volume 59, Issue 5, Pages (May 2001)
Volume 57, Issue 2, Pages (October 2000)
Volume 66, Issue 6, Pages (December 2004)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells  Carl F. Verkoelen, Burt G. van Der.
Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis  Akira Shimizu, Kazuhiko Yamada, David.
Volume 63, Issue 3, Pages (March 2003)
Acid-base profile in patients on PD
Prasad V. Gade, MD, José A. Andrades, PhD, Marcel E
Volume 65, Issue 1, Pages (January 2004)
Proliferation, Cell Cycle Exit, and Onset of Terminal Differentiation in Cultured Keratinocytes: Pre-Programmed Pathways in Control of C-Myc and Notch1.
Volume 68, Issue 1, Pages (July 2005)
Vitamin C Regulates Keratinocyte Viability, Epidermal Barrier, and Basement Membrane In Vitro, and Reduces Wound Contraction After Grafting of Cultured.
Volume 64, Issue 2, Pages (August 2003)
Velocity Fields in a Collectively Migrating Epithelium
Volume 66, Issue 6, Pages (December 2004)
Volume 66, Issue 5, Pages (November 2004)
Volume 69, Issue 10, Pages (May 2006)
Volume 63, Issue 3, Pages (March 2003)
Volume 60, Issue 2, Pages (August 2001)
Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells  Carl F. Verkoelen, Burt G. van Der.
Morphogenesis during mouse embryonic kidney explant culture
Volume 62, Issue 4, Pages (October 2002)
Volume 64, Issue 6, Pages (December 2003)
Volume 53, Issue 5, Pages (May 1998)
Robert Earl Routh, John Hardwick Johnson, Kevin John McCarthy 
Volume 63, Issue 2, Pages (February 2003)
Mechanisms of the proteinuria induced by Rho GTPases
Volume 57, Issue 2, Pages (October 2000)
Hyaluronan and proximal tubular cell migration
P. Coutinho, C. Qiu, S. Frank, C. M. Wang, T. Brown, C. R. Green, D. L
Volume 59, Issue 6, Pages (June 2001)
Volume 56, Issue 4, Pages (October 1999)
Marie-Thérèse Leccia  Journal of Investigative Dermatology 
Volume 59, Issue 5, Pages (May 2001)
Melanie Breetveld, Cornelia D. Richters, Thomas Rustemeyer, Rik J
Shiga toxin 1 elicits diverse biologic responses in mesangial cells
Volume 61, Issue 6, Pages (June 2002)
Volume 9, Issue 4, Pages (April 2004)
Volume 54, Issue 6, Pages (January 1998)
Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development  Yoichi Miyazaki, Keisuke Oshima,
Volume 60, Issue 5, Pages (November 2001)
Hsin-Hui Wang, Tzong-Yann Lee, Ching-Yuang Lin  Kidney International 
Volume 64, Issue 5, Pages (November 2003)
Volume 68, Issue 4, Pages (October 2005)
Volume 58, Issue 3, Pages (September 2000)
Volume 84, Issue 3, Pages (March 2003)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
A Murine Living Skin Equivalent Amenable to Live-Cell Imaging: Analysis of the Roles of Connexins in the Epidermis  Eve E. Kandyba, Malcolm B. Hodgins,
Volume 56, Issue 4, Pages (October 1999)
Glomerular injury is exacerbated in diabetic integrin α1-null mice
The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions  P.M. ter Wee, R.H.J. Beelen, J.
Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro  Sue Yung, Gareth J. Thomas, Malcolm Davies 
Volume 65, Issue 6, Pages (June 2004)
Promotion of Human Dermal Fibroblast Migration, Matrix Remodelling and Modification of Fibroblast Morphology within a Novel 3D Model by Lucilia sericata.
Volume 55, Issue 4, Pages (April 1999)
A Novel Role of Fibrin in Epidermal Healing: Plasminogen-Mediated Migration and Selective Detachment of Differentiated Keratinocytes  David J. Geer, Stelios.
Delayed Cutaneous Wound Healing in Mice Lacking Solute Carrier 11a1 (Formerly Nramp1): Correlation with Decreased Expression of Secretory Leukocyte Protease.
Volume 60, Issue 3, Pages (September 2001)
Volume 61, Issue 5, Pages (May 2002)
Volume 97, Issue 7, Pages (October 2009)
Melanoma Cells Control HA Synthesis in Peritumoral Fibroblasts via PDGF-AA and PDGF-CC: Impact on Melanoma Cell Proliferation  Anja Willenberg, Anja Saalbach,
Volume 64, Issue 1, Pages (July 2003)
Volume 68, Issue 3, Pages (September 2005)
Volume 57, Issue 2, Pages (October 2000)
The International Pediatric Peritonitis Registry: Starting to walk
Keratinocyte-Derived Granulocyte-Macrophage Colony Stimulating Factor Accelerates Wound Healing: Stimulation of Keratinocyte Proliferation, Granulation.
Gaddiel Yonathan Ouaknin, Pinhas Zvi Bar-Yoseph  Biophysical Journal 
Presentation transcript:

Volume 64, Issue 6, Pages 2280-2290 (December 2003) Image analysis of remesothelialization following chemical wounding of cultured human peritoneal mesothelial cells: The role of hyaluronan synthesis  Takashi Horiuchi, Keiichi Miyamoto, Sunao Miyamoto, Mika Fujita, Nami Sano, Kyoko Minamiyama, Yuichirou Fujimura, Koichi Nagasawa, Chie Otsuka, Yuji Ohta  Kidney International  Volume 64, Issue 6, Pages 2280-2290 (December 2003) DOI: 10.1046/j.1523-1755.2003.00325.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 A flow diagram of the microscopic image acquisition and analysis system. Abbreviations are: PC, personal computer; CCD, charged-coupling device. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 A schematic diagram of the double-layered matrix model for evaluating effect of hyluronan (HA)-contained type I collagen matrices on remesothelialization. HPMC is human peritoneal mesothelial cells. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Representative images of the wound-healing process occurring in chemically wounded human peritoneal mesothelial cells (HPMCs) (about 1.5mm of the wounded area) exposed to culture medium for 30 minutes following chemical wounding, and medium then replaced with 0.3% fetal calf serum (FCS) medium for up to 96hours. Since the cells at the edges of each frame showed poor mobility, the wounded area would be remesothelialized by migration of the cells along the wound edge and/or proliferation of cells away from the wound edge. The closure time was about 60hours. There was slight but noticable migration even during the post wound closure period (72hours ∼ 96hours). Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Changes in (A) the denuded area, (B) the cell number, and (C) the cell area, as a function of the healing time in control cultures (exposed to culture medium 1.27 ± 0.55mm of the equivalent diameter;N = 5). The denuded area was remesothelialized linearly until 36hours postinjury followed by a decreased rate of remesothelialization. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Changes in (A) the denuded area, (B) the cell number, and (C) the cell area as a function of the healing time in cultures exposed to neutralized peritoneal dialysis solutions (1.40 ± 1.15mm of the equivalent diameter;N = 3). The rate of remesothelialization was equivalent to that of control cultures. However, the increase in cell number was somewhat faster than that observed in control cultures, resulting in less change in the cell size of the human peritoneal mesothelial cells (HPMCs). According to statistical analysis (Mann-Whitney U test) in cell number between control group and neutral peritoneal dialysis group, there were significant differences at 48, 60, 72, 84, and 96hours (P < 0.05) during healing period. There was no statisitically significant difference between both groups in the other two parameters. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 (A) Eight cells investigated for cell tracking study and (B) the different mobilities (giant cells, upper panel; adjacent to the wound edge, middle panel; and apart from the wound edge, lower panel) associated with the different morphologies and locations of the human peritoneal mesothelial cells (HPMCs). Cells marked numbers 1 and 3, polygonal cells about 20 cells away from the wound edge, tended to proliferate as opposed to the other HPMCs. Cells marked numbers 2 and 7, the giant cells, defined as having a mean diameter of HPMC + 2 SD, did not form lamellapodia. Cell marked number 4; the polygonal cell found along the wound edge, mobilized relatively fast exhibiting lamellapodia. Cells marked number 5, the polygonal cell approximately two to three layers away from the wound edge, did not migrate to any extent when compared to the cells along the wound edge. Cell marked number 6, a rounded cell typically found along the wound edge but very few in number, migrated so rapidly moving large distances that it soon went out of view. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 (A) Eight cells investigated for cell tracking study and (B) the different mobilities (giant cells, upper panel; adjacent to the wound edge, middle panel; and apart from the wound edge, lower panel) associated with the different morphologies and locations of the human peritoneal mesothelial cells (HPMCs). Cells marked numbers 1 and 3, polygonal cells about 20 cells away from the wound edge, tended to proliferate as opposed to the other HPMCs. Cells marked numbers 2 and 7, the giant cells, defined as having a mean diameter of HPMC + 2 SD, did not form lamellapodia. Cell marked number 4; the polygonal cell found along the wound edge, mobilized relatively fast exhibiting lamellapodia. Cells marked number 5, the polygonal cell approximately two to three layers away from the wound edge, did not migrate to any extent when compared to the cells along the wound edge. Cell marked number 6, a rounded cell typically found along the wound edge but very few in number, migrated so rapidly moving large distances that it soon went out of view. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 7 Percent representation of destinies of the 100 cells during remesothelialization process. Approximately 68% of the cells remained after chemical wounding migrated centripetally in a wide range of mobility while 26% of them proliferated. The rests of them (6%) were the enlarged cells (GC), which did not show any proliferation but mobilized. *29% of the migrated and 38% of the proliferated cells failed to track, respectively (presumably cell death and subsequent detachment). Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 8 Identification of cell proliferation using bromodeoxyuridine incorporations into cells. (a) Phase-contrast microscopic finding of the human peritoneal mesothelial cells (HPMCs) in a remodeling phase after chemical wounding. Arrows indicate the wounding edge. Scattered incorpolation of bromodeoxyuridine into the HPMC apart from the wounding edge was observed. (b) Phase-contrast microscopic finding of the HPMCs after wound closing. There was few noticeable stained region of bromodeoxyuridine after wound closing. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 8 Identification of cell proliferation using bromodeoxyuridine incorporations into cells. (a) Phase-contrast microscopic finding of the human peritoneal mesothelial cells (HPMCs) in a remodeling phase after chemical wounding. Arrows indicate the wounding edge. Scattered incorpolation of bromodeoxyuridine into the HPMC apart from the wounding edge was observed. (b) Phase-contrast microscopic finding of the HPMCs after wound closing. There was few noticeable stained region of bromodeoxyuridine after wound closing. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 9 Histochemical staining of wounded human peritoneal mesangial cells (HPMCs) by biotin-conjugated hyaluronan-binding protein (B-HABP) conjugated to streptavidin. (A) In this experiment, the denuded area was completely remesothelialized 24hours after chemical wounding. The stained area was localized to the healed area where remesothelialization was complete. After 48hours, the stained area was still visible but somewhat diffuse but by 72hours was no longer visible. (B) Changes in B-HABP staining, quantified as a function of the healing time (exposed to culture medium) (N = 7; *P < 0.05). Only 12.5% of mesothelial cells (12,000 pixels out of 786,432 of total number of pixels) stained for B-HABP even before chemical injury. Following injury, 4.3 times and 5.2 times larger pixel numbers were counted at 24hours and 48hours, respectively. Thereafter, staining was reduced to 1.7 to 2.0 times the background levels. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 9 Histochemical staining of wounded human peritoneal mesangial cells (HPMCs) by biotin-conjugated hyaluronan-binding protein (B-HABP) conjugated to streptavidin. (A) In this experiment, the denuded area was completely remesothelialized 24hours after chemical wounding. The stained area was localized to the healed area where remesothelialization was complete. After 48hours, the stained area was still visible but somewhat diffuse but by 72hours was no longer visible. (B) Changes in B-HABP staining, quantified as a function of the healing time (exposed to culture medium) (N = 7; *P < 0.05). Only 12.5% of mesothelial cells (12,000 pixels out of 786,432 of total number of pixels) stained for B-HABP even before chemical injury. Following injury, 4.3 times and 5.2 times larger pixel numbers were counted at 24hours and 48hours, respectively. Thereafter, staining was reduced to 1.7 to 2.0 times the background levels. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 10 Histochemical staining using biotin-conjugated hyaluronan-binding protein (B-HABP) conjugated with streptavidin in comparison of the stained area between 50% healing and 100% healing. (A) No linear correlation between the wound healed area and hyaluronan concentration was seen. (B) Changes in B-HABP staining, quantified as a function of % healing (exposed to culture medium) (N = 6; *P < 0.05). Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 10 Histochemical staining using biotin-conjugated hyaluronan-binding protein (B-HABP) conjugated with streptavidin in comparison of the stained area between 50% healing and 100% healing. (A) No linear correlation between the wound healed area and hyaluronan concentration was seen. (B) Changes in B-HABP staining, quantified as a function of % healing (exposed to culture medium) (N = 6; *P < 0.05). Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 11 Effect of hyaluronan (HA)-contained collagen matrices on remesothelialization. The closing rate was slightly faster in the hyaluronan-contained group than type I collagen alone, not statistically significant. Kidney International 2003 64, 2280-2290DOI: (10.1046/j.1523-1755.2003.00325.x) Copyright © 2003 International Society of Nephrology Terms and Conditions